Ali Tavassoli

Company: Curve Therapeutics

Job title: CSO

Seminars:

Identifying & Developing Cyclic Peptide KRAS Inhibitors Through a Novel Screening Platform 12:15 pm

Showcasing how Curve’s MicrocycleTM drug discovery platform utilizes a genetically-encoded intracellular library of 3.2 x 106 cyclic peptides in combination with mammalian cell-based screening for inhibitor identification Examining how intracellular screening holds several advantages over traditional in vitro screening approaches to drug discovery and has led to the identification of a series of KRAS inhibitors…Read more

day: Day Two Track A AM